In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors — Stella

Home/Cancer Survivors/

View on ClinicalTrials.gov

Recruiting

Back to Cancer Survivors trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

Spain

Gil y Morte Primary Care Practice, Valencia

Mallilla Primary Care Practice, Valencia

Russafa Primary Care Practice, Valencia

Key details

Sponsor

University College, London

Collaborators

IQAir AG, PremaLabs Diagnostics, Ltd

Enrollment target

~10 participants

Started

January 2026

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.